Operating Lease, Right-of-Use Asset of ESSA Pharma Inc. from 30 Sep 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ESSA Pharma Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 30 Jun 2025.
  • ESSA Pharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ESSA Pharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 -$318,275 -100% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 $248,017 -$92,923 -27% 31 Mar 2025 10-Q 08 May 2025 2025 Q2
Q4 2024 $272,057 -$91,088 -25% 31 Dec 2024 10-Q 11 Feb 2025 2025 Q1
Q3 2024 $295,471 +$227,463 +334% 30 Sep 2024 10-Q 13 Aug 2025 2025 Q3
Q2 2024 $318,275 +$223,117 +234% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q3
Q1 2024 $340,940 +$215,335 +171% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $363,145 +$207,093 +133% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q1
Q3 2023 $68,008 -$118,491 -64% 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 $95,158 -$121,788 -56% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q3
Q1 2023 $125,605 -$121,788 -49% 31 Mar 2023 10-Q 09 May 2023 2023 Q2
Q4 2022 $156,052 -$121,787 -44% 31 Dec 2022 10-Q 07 Feb 2023 2022 Q1
Q3 2022 $186,499 -$121,787 -40% 30 Sep 2022 10-K 17 Dec 2024 2024 FY
Q2 2022 $216,946 -$80,587 -27% 30 Jun 2022 10-Q 08 Aug 2023 2023 Q3
Q1 2022 $247,393 -$93,732 -27% 31 Mar 2022 10-Q 09 May 2023 2023 Q2
Q4 2021 $277,839 +$250,258 +907% 31 Dec 2021 10-Q 07 Feb 2023 2022 Q1
Q3 2021 $308,286 +$253,124 +459% 30 Sep 2021 10-K 12 Dec 2023 2023 FY
Q2 2021 $297,533 +$214,790 +260% 30 Jun 2021 10-Q 04 Aug 2022 2022 Q3
Q1 2021 $341,125 +$230,801 +209% 31 Mar 2021 10-Q 10 May 2022 2022 Q2
Q4 2020 $27,581 -$110,324 -80% 31 Dec 2020 10-Q 03 Feb 2022 2022 Q1
Q3 2020 $55,162 +$55,162 30 Sep 2020 10-K 13 Dec 2022 2022 FY
Q2 2020 $82,743 30 Jun 2020 10-Q 16 Aug 2021 2021 Q3
Q1 2020 $110,324 31 Mar 2020 10-Q 06 May 2021 2021 Q2
Q4 2019 $137,905 31 Dec 2019 10-Q 11 Feb 2021 2021 Q1
Q3 2019 $0 30 Sep 2019 10-K 18 Nov 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.